🔎 Trials Near Me

Home › Sovrappeso › Georgia

Studi clinici su Sovrappeso nello stato di Georgia

36 studi su Sovrappeso cercano partecipanti presso sedi nello stato di Georgia.

Città nello stato di Georgia

Testo ufficiale dello studio (inglese)

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

  • Children's Healthcare Atlanta, Atlanta
  • Columbus Research Foundation, Columbus
  • Accel Research Sites-NeuroStudies, Decatur
  • e altri 1
In reclutamentoFase 3
Età da 8 a 18 · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07253285

AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight

  • Hope Clin Res & Wellness, Conyers
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07720271

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

  • Conquest Research, Atlanta
  • Eastside Bariatric and Gen Surg, Snellville
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07668414

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

  • SKY Clinical Research Network Group-Brown, Atlanta
  • HOPE Clinical Research & Wellness, Conyers
  • Care Access - Dalton Walmart, Dalton
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07794579

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

  • Research Site, Stockbridge
  • Research Site, Woodstock
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07776509

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

  • Children's Healthcare of Atlanta - Center for Advanced Pediatrics, Atlanta
In reclutamentoFase 3
Età da 6 a 17 · Tutti i sessi · Aggiornato il 24 set 2026 · NCT06672549

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

  • Teak Research Consults - Dunwoody, Dunwoody
  • Teak Research Consults, Lawrenceville
  • The Jones Center Clinical Research, Macon
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

  • Teak Research Consults - Dunwoody, Dunwoody
  • Center for Advanced Research & Education, Gainesville
  • Clinical Research Atlanta, Stockbridge
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07392190

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

  • Research Site, Woodstock
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07784270

A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

  • Teak Research Consults, Lawrenceville
  • EBGS Clinical Research Center, Snellville
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07369011

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  • East Coast Institute for Research LLC at Canton Georgia, Canton
  • The Jones Center Clinical Research, Macon
  • Velocity Clinical Research - Savannah, Savannah
In reclutamentoFase 3
Età da 45 a 99 · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07037433

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

  • Teak Research Consults - Dunwoody, Dunwoody
  • Teak Research Consults, Lawrenceville
  • Clinical Research Atlanta, Stockbridge
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07321886

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

  • Orita Clinical Research, Decatur
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07353931

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities

  • AURORA-1 Clinical Site, Canton
  • AURORA-1 Clinical Site, Decatur
  • AURORA-1 Clinical Site, Union City
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07743463

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

  • AURORA-2 Clinical Site, Canton
  • AURORA-2 Clinical Site, Decatur
  • AURORA-2 Clinical Site, Union City
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 16 set 2026 · NCT07743450

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

  • Centricity Research Columbus Georgia Multispecialty, Columbus
  • Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07351058

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

  • Balanced Life Health Care Solutions/SKYCRNG, Lawrenceville
  • Physicians Research Associates, Lawrenceville
  • Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
  • e altri 1
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 14 set 2026 · NCT06897475

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

  • Rophe Adult and Pediatric Medicine/SKYCRNG, Union City
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 14 set 2026 · NCT07351045

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  • Conquest Research, Atlanta
  • Physicians Research Associates, Lawrenceville
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 11 set 2026 · NCT07571005

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

  • ACCOMPLISH-2 Research Site, Atlanta
  • ACCOMPLISH-2 Research Site, Columbus
  • ACCOMPLISH-2 Research Site, Lawrenceville
  • e altri 2
In reclutamentoFase 3Volontari sani benvenuti
Età da 18 a 79 · Tutti i sessi · Aggiornato il 11 set 2026 · NCT07654374

Cottonseed Oil Versus Matched PUFA Effects

  • University of Georgia, Athens
In reclutamentoVolontari sani benvenuti
Età da 25 a 75 · Tutti i sessi · Aggiornato il 9 set 2026 · NCT06382298

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

  • NeuroTrials Research, Inc., Atlanta
  • Physicians Research Associates, Lawrenceville
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07571109

Intermittent Cottonseed Oil Consumption

  • University of Georgia, Athens
In reclutamentoVolontari sani benvenuti
Età da 25 a 75 · Tutti i sessi · Aggiornato il 9 set 2026 · NCT07246408

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

  • SKY Clinical Research Network Group-Brown, Atlanta
  • Teak Research Consults, Lawrenceville
  • AGILE Clinical Research Trials, LLC, Sandy Springs
  • e altri 2
In reclutamentoFase 2
Età da 18 a 75 · Tutti i sessi · Aggiornato il 8 set 2026 · NCT07215559

A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight

  • Hope Clin Res & Wellness, Conyers
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 4 set 2026 · NCT07745504

Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes

  • Kailera Clinical Site, Decatur
  • Kailera Clinical Site, Lilburn
  • Kailera Clinical Site, Marietta
  • e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT07284901

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

  • Center for Advanced Research and Education, Gainesville
  • Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City
In reclutamentoFase 3
Età da 18 a 99 · Tutti i sessi · Aggiornato il 3 set 2026 · NCT07684235

Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes

  • Kailera Clinical Site, Lilburn
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 3 set 2026 · NCT07284875

Wild Blueberries for Gut, Brain, and Cardiometabolic Health in Prediabetes

  • Georgia State University, Atlanta
In reclutamento
Età da 20 a 65 · Donne · Aggiornato il 2 set 2026 · NCT06735651

Wild Blueberries for Gut, Brain, and Heart Health in Adults With High Blood Pressure

  • Georgia State University, Atlanta
In reclutamento
Età da 45 a 65 · Tutti i sessi · Aggiornato il 2 set 2026 · NCT06735599

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

  • Nsc Research, Johns Creek
  • Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group, Union City
  • North Georgia Clinical Research, Woodstock
In reclutamentoFase 3
Età da 18 a 99 · Tutti i sessi · Aggiornato il 27 ago 2026 · NCT07575399

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

  • Research Site, Stockbridge
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 ago 2026 · NCT07784725

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

  • ACCOMPLISH-1 Research Site, Buford
  • ACCOMPLISH-1 Research Site, Columbus
  • ACCOMPLISH-1 Research Site, Lawrenceville
  • e altri 2
In reclutamentoFase 3
Età da 18 a 79 · Tutti i sessi · Aggiornato il 10 ago 2026 · NCT07654361

Prescription of Step Counts for Targeted Changes in Body Composition and Cardiometabolic Risk in Overweight/Obese Adults

  • Kennesaw State Universityh, Kennesaw
In reclutamentoVolontari sani benvenuti
Età 20 e oltre · Tutti i sessi · Aggiornato il 27 ott 2025 · NCT07221279

Lifestyle Intervention for Healthy Change

  • Augusta University, Augusta
In reclutamentoVolontari sani benvenuti
Età da 18 a 40 · Tutti i sessi · Aggiornato il 19 feb 2025 · NCT05956574

Fonte: ClinicalTrials.gov, dati recuperati il 3 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.